| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
|
US7396841 (Pediatric) | TAKEDA PHARMS NA | Injections |
Feb, 2022
(1 year, 7 months ago) | |
Prevacid Iv is owned by Takeda Pharms Na.
Prevacid Iv contains Lansoprazole.
Prevacid Iv has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Prevacid Iv are:
- US7396841*PED
Prevacid Iv was authorised for market use on 27 May, 2004.
Prevacid Iv is available in injectable;intravenous dosage forms.
The generics of Prevacid Iv are possible to be released after 17 February, 2022.
Drugs and Companies using LANSOPRAZOLE ingredient
Market Authorisation Date: 27 May, 2004
Treatment: NA
Dosage: INJECTABLE;INTRAVENOUS
More Information on Dosage
PREVACID IV family patents
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic